(Reuters) – Moderna Inc said on Wednesday it had initiated submission of data to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine.
(Reporting by Mrinalika Roy and Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)
